Drug Guide
Polyethylene Glycol 3350
Classification
Therapeutic: Laxative
Pharmacological: Osmotic laxative
FDA Approved Indications
- Occasional constipation
Mechanism of Action
Polyethylene glycol 3350 works by retaining water in the stool, resulting in softer stools and more frequent bowel movements.
Dosage and Administration
Adult: 17 grams (1 heaping tablespoon) dissolved in 4 to 8 ounces of fluid once daily as needed.
Pediatric: Not approved for use in children under 17 years old without medical supervision.
Geriatric: Use with caution; no specific dose adjustments, but monitor for dehydration or electrolyte imbalance.
Renal Impairment: Use cautiously; monitor electrolytes.
Hepatic Impairment: No specific dose adjustment required.
Pharmacokinetics
Absorption: Minimal; the drug acts locally in the gut.
Distribution: Not significantly absorbed systemically.
Metabolism: Not metabolized, remains unchanged.
Excretion: Excreted largely unchanged in feces.
Half Life: Not applicable, as it acts locally.
Contraindications
- Intestinal obstruction
- Gastrointestinal perforation or obstruction
- Severe inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis)
Precautions
- Use with caution in patients with difficulty swallowing, dehydration, or electrolyte imbalances. Prolonged use may lead to dependence.
Adverse Reactions - Common
- Bloating (Rare)
- Abdominal cramps (Rare)
- Nausea (Rare)
Adverse Reactions - Serious
- Electrolyte imbalance (e.g., hyponatremia, hypokalemia) (Infrequent)
- Severe allergic reactions (Rare)
Drug-Drug Interactions
- Sodium bicarbonate, other osmotic laxatives, or medications affecting electrolyte balance.
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor bowel movements, hydration status, electrolyte levels.
Diagnoses:
- Constipation related to decreased gut motility or diet.
Implementation: Administer as prescribed; dissolve the powder completely in fluid.
Evaluation: Assess for regular bowel movements, absence of bloating, or discomfort.
Patient/Family Teaching
- Take as directed, dissolved in liquid.
- Avoid excessive use to prevent dependence.
- Report severe diarrhea, abdominal pain, or signs of electrolyte imbalance.
Special Considerations
Black Box Warnings:
- None
Genetic Factors: None specified.
Lab Test Interference: May cause alterations in stool tests due to increased water content.
Overdose Management
Signs/Symptoms: Severe diarrhea, electrolyte imbalance, dehydration.
Treatment: Discontinuation of medication, correction of electrolytes, and supportive care.
Storage and Handling
Storage: Store at room temperature, 20-25°C (68-77°F).
Stability: Stable under recommended storage conditions.